Radiotherapy & Oncology
Volume 93, Issue 2 , Pages 259-265, November 2009

Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes?

Department of Radiation Oncology, University of Wuerzburg, Wuerzburg, Germany

Received 14 May 2009; received in revised form 5 July 2009; accepted 2 August 2009. published online 14 September 2009.

Abstract 

Purpose

To compare step-and-shoot intensity-modulated radiotherapy (ss-IMRT) with volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes with a simultaneous integrated boost (SIB).

Materials and methods

This retrospective planning study was based on 20 patients composed of prostate cancer (n=5), postoperative (n=5) or primary (n=5) radiotherapy for pharyngeal cancer and for cancer of the paranasal sinuses (n=5); a SIB with two or three dose levels was planned in all patients. For each patient, one ss-IMRT plan with direct-machine-parameter optimization (DMPO) and VMAT plans with one to three arcs (SmartArc technique) were generated in the Pinnacle planning system.

Results

Single arc VMAT improved target coverage and dose homogeneity in radiotherapy for prostate cancer. Two and three VMAT arcs were required to achieve equivalent results compared to ss-IMRT in postoperative and primary radiotherapy for pharyngeal cancer, respectively. In radiotherapy for cancer of the paranasal sinuses, multiarc VMAT resulted in increased spread of low doses to the lenses and decreased target coverage in the region between the orbits.

Conclusions

The complexity of the target volume determined whether single arc VMAT was equivalent to ss-IMRT. Multiple arc VMAT improved results compared to single arc VMAT at cost of increased delivery times, increased monitor unites and increased spread of low doses.

Keywords: Step-and-shoot intensity-modulated radiotherapy, Volumetric-modulated arc therapy, Prostate cancer, Pharyngeal cancer, Cancer of the paranasal sinuses

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-8140(09)00451-4

doi:10.1016/j.radonc.2009.08.015

Radiotherapy & Oncology
Volume 93, Issue 2 , Pages 259-265, November 2009